Dr. Jorge G. Gomez-Gutierrez earned his B.S. in 2001 and his Ph.D. in 2006 from the University of Nuevo León. He is currently an Associate Professor of Pediatrics and a NextGen Precision Health Investigator. Dr. Gomez-Gutierrez's research focuses on microbial-based cancer therapies, particularly using virus- and bacteria-based treatments to inhibit tumor growth and induce oncolysis or immune responses where conventional therapies are insufficient. His lab studies conditionally replicating adenoviruses (oncolytic adenoviruses) and the lactic acid bacterium Lactococcus lactis, commonly used in the dairy industry.